Keyan Salari
Keyan Salari
Urologic Oncologist, Massachusetts General Hospital, Harvard Medical School
Verified email at
Cited by
Cited by
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery
J Kao, K Salari, M Bocanegra, YL Choi, L Girard, J Gandhi, KA Kwei, ...
PloS one 4 (7), e6146, 2009
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
J Lapointe, C Li, CP Giacomini, K Salari, S Huang, P Wang, M Ferrari, ...
Cancer research 67 (18), 8504-8510, 2007
Population stratification confounds genetic association studies among Latinos
S Choudhry, NE Coyle, H Tang, K Salari, D Lind, SL Clark, HJ Tsai, ...
Human genetics 118 (5), 652-664, 2006
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma
S Choudhry, N Ung, PC Avila, E Ziv, S Nazario, J Casal, A Torres, ...
American journal of respiratory and critical care medicine 171 (6), 563-570, 2005
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer
KA Kwei, YH Kim, L Girard, J Kao, M Pacyna-Gengelbach, K Salari, J Lee, ...
Oncogene 27 (25), 3635-3640, 2008
ADAM33 is not associated with asthma in Puerto Rican or Mexican populations
DL Lind, S Choudhry, N Ung, E Ziv, PC Avila, K Salari, C Ha, EG Lovins, ...
American journal of respiratory and critical care medicine 168 (11), 1312-1316, 2003
Genetic admixture and asthma‐related phenotypes in Mexican American and Puerto Rican asthmatics
K Salari, S Choudhry, H Tang, M Naqvi, D Lind, PC Avila, NE Coyle, ...
Genetic Epidemiology: The Official Publication of the International Genetic …, 2005
Genomic instability in breast cancer: pathogenesis and clinical implications
KA Kwei, Y Kung, K Salari, IN Holcomb, JR Pollack
Molecular oncology 4 (3), 255-266, 2010
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
S Huang, ZG Gulzar, K Salari, J Lapointe, JD Brooks, JR Pollack
Oncogene 31 (37), 4164-4170, 2012
Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer
KA Kwei, MD Bashyam, J Kao, R Ratheesh, EC Reddy, YH Kim, ...
PLoS genetics 4 (5), e1000081, 2008
The dawning era of personalized medicine exposes a gap in medical education
K Salari
PLoS medicine 6 (8), e1000138, 2009
Personalized medicine: hope or hype?
K Salari, H Watkins, EA Ashley
European heart journal 33 (13), 1564-1570, 2012
Evidence that personal genome testing enhances student learning in a course on genomics and personalized medicine
K Salari, KJ Karczewski, L Hudgins, KE Ormond
PLoS One 8 (7), e68853, 2013
Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
YH Kim, KA Kwei, L Girard, K Salari, J Kao, M Pacyna-Gengelbach, ...
Oncogene 29 (10), 1421-1430, 2010
CDX2 is an amplified lineage-survival oncogene in colorectal cancer
K Salari, ME Spulak, J Cuff, AD Forster, CP Giacomini, S Huang, ME Ko, ...
Proceedings of the National Academy of Sciences 109 (46), E3196-E3205, 2012
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer
IN Holcomb, JM Young, IM Coleman, K Salari, DI Grove, L Hsu, LD True, ...
Cancer research 69 (19), 7793-7802, 2009
ESR1 gene amplification in breast cancer: a common phenomenon?
HM Horlings, A Bergamaschi, SH Nordgard, YH Kim, W Han, DY Noh, ...
Nature genetics 40 (7), 807-808, 2008
Transcriptional mediators of treatment resistance in lethal prostate cancer
MX He, MS Cuoco, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, ...
Nature medicine 27 (3), 426-433, 2021
Personal genome testing in medical education: student experiences with genotyping in the classroom
SL Vernez, K Salari, KE Ormond, SSJ Lee
Genome medicine 5 (3), 1-8, 2013
Biologically informed deep neural network for prostate cancer discovery
HA Elmarakeby, J Hwang, R Arafeh, J Crowdis, S Gang, D Liu, ...
Nature 598 (7880), 348-352, 2021
The system can't perform the operation now. Try again later.
Articles 1–20